←
Quezada Lab330 posts
Quezada Lab avatar

Quezada Lab

@QuezadaLab

Immune Regulation and Tumour Immunotherapy Group led by @squezadd, based at the Cancer Institute of University College of London, UCL.

◷ Joined September 2018▧ 29 Photos and videos
Quezada Lab avatar
Quezada Lab@QuezadaLab·Apr 30

Congrats to Aurélien Marabelle’s team — intratumoural anti-CTLA-4 links Treg reduction with FcγR⁺ myeloid context, underscoring the FcγR landscape as a key determinant of CPI activity and translation. nature.com/articles/s41586-0…

Cancer Grand Challenges avatar
⟳ Quezada Lab retweeted
Cancer Grand Challenges@CancerGrand·Apr 30

Congratulations to @CharlesSwanton, Mariam Jamal-Hanjani and colleagues on their fascinating analysis of the evolution of lung cancer metastasis published in @Nature! nature.com/articles/s41586-0…

Miriam Merad, MD, PhD avatar
⟳ Quezada Lab retweeted
Miriam Merad, MD, PhD@MiriamMerad·Apr 30

Thrilled to see a new paper led by the outstanding @Brown_lab1, now out in Nature Biotechnology. We provide mechanistic insights into how mRNA vaccines work. challenging key assumptions and offering new ways to control vaccine activity. (1/3) Read here: nature.com/articles/s41587-0…

Walczak Lab avatar
⟳ Quezada Lab retweeted
Walczak Lab@Walczak_Lab·Mar 6

Excited to share our new work uncovering a previously unknown mechanism identifying ANKIB1 as the E3 ligase that writes a critical new letter of the ubiquitin code central for immune signalling: K11-linked ubiquitin nature.com/articles/s41556-0…

Miriam Merad, MD, PhD avatar
⟳ Quezada Lab retweeted
Miriam Merad, MD, PhD@MiriamMerad·6 Oct 2025

Immunology takes center stage again at the #NobelPrize! Congratulations to Mary Brunkow, Fred Ramsdell & Shimon Sakaguchi for uncovering how regulatory T cells maintain immune tolerance—a discovery that transformed our understanding of autoimmunity and cancer immunotherapy

Quezada Lab avatar
Quezada Lab@QuezadaLab·17 Sep 2025

Are you looking for a Clinical Research Training Fellowship? Do you want join our team working in cancer immunology and immunotherapy? Check this great opportunity from @CRUKCOLcentre colcc.ac.uk/clinical-researc…  and contact our team to discuss our proposed project

Richard Jenner avatar
⟳ Quezada Lab retweeted
Richard Jenner@RegGenomics·12 Sep 2025

Pleased to share our preprint describing a central role for post-transcriptional processes in the response to cancer immunotherapy. Huge amount of work led by Maria Vila de Mucha and @julia_hlond in collaboration with @QuezadaLab and @MartT_babraham 1/8 biorxiv.org/content/10.1101/…

soria avatar
⟳ Quezada Lab retweeted
soria@jsoriamd·25 Apr 2025

CHIP is a common, age-related condition where mutated blood stem cells expand without causing blood disorders. CHIP raises the risk of hematological malignancies, chronic inflammatory diseases (like heart & lung disease), & lung cancer. This manuscript shows that CHIP somatic clones in blood—especially TET2 mutant ones—migrate into tumors, reshape immunity, drive progression, and promote recurrence. The ability of a somatic clonal expansion in the hematopoietic compartment, to regulate malignant progression in another tissue represents a new perspective in cancer biology. #CHIP #LCMS #cancer #biology #AACR25 nejm.org/doi/full/10.1056/NE…

Post attachment
Quezada Lab avatar
Quezada Lab@QuezadaLab·24 Apr 2025

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies: cell.com/immunity/fulltext/S… Amazing collaboration led by @CR_UK funded @QuezadaLab @galvez_cancino @uclcancer and colleagues!